NCT04080128

Brief Summary

This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients and practitioners about the side effects, mechanism, and discontinuation of soft bifocal contact lens myopia control. The first three aims examine the association between biological variables that can be measured non-invasively and myopia progression, and they will be conducted regardless of the outcome of the currently in progress BLINK Study. The last three specific aims will be conducted if soft bifocal contact lenses slowed myopia progression by 30% or more in the BLINK Study, and they can be investigated with very few additional measurements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
248

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 6, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

September 9, 2019

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 4, 2024

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

May 6, 2026

Completed
Last Updated

May 6, 2026

Status Verified

March 1, 2026

Enrollment Period

4.3 years

First QC Date

August 27, 2019

Results QC Date

May 20, 2025

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • The Statistical Correlation Between Three-year Change in Choroidal Thickness and Three-year Change in Axial Length

    test the hypothesis that thinner subfoveal choroidal thickness (a layer of blood vessels) is associated with the outcome of greater axial elongation (eye growth) The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.

    Three years

  • The Statistical Correlation Between iPRGC Activity at BLINK2 Baseline and Three-year Change in Axial Length

    test the hypothesis that less ipRGC activity (cells in the back of the eye as measured by blue light-driven inputs to the pupil response - measured by the blue decay coefficient) as measured at the Baseline BLINK 2 is associated with greater axial elongation (eye growth) over three years The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.

    Three years

  • The Statistical Correlation Between Light Levels Measured at Baseline and Three-year Change in Axial Length

    test the hypothesis that exposure to light levels over 1000 lux as measured at the Baseline BLINK2 visit is associated with less axial elongation (eye growth) over three years The hypothesis relates to the two years of multifocal contact lens wear and one year of single vision contact lens wear. As such, it uses the entire sample which experiences the same contact lens wear in the BLINK2 Study.

    Three years

  • Three-year Choroidal Thickness Change

    The three-year change from baseline to three years for choroidal thickness.

    3 years

  • Duration of Exposure to Light Levels Exceeding 1000 Lux at Baseline

    Baseline light exposure as measured by minutes at light levels over 1000 lux. Light exposure was monitored using the Actiwatch2 (Phillips Respironics), a light-sensing and logging watch worn on the wrist. Participants wore the device for a 1 week period to monitor environmental light exposure. The illuminance was measured in lux every minute. Data were scrubbed of periods where the watch was not worn or other artifacts. Light levels over 1000 lux were added to determine time outdoors in minutes.

    Baseline

  • Baseline iPRGC Activity

    Baseline iPRGC activity (cells in the back of the eye as measured by blue light-driven inputs to the pupil response - measured by the blue decay coefficient). The Blue Decay Coefficient represents the rate at which the pupil redilates in the dark after exposure to multiple 5-second pulses of red and blue light. The redilation data are fit by an exponential decay function eβt where t is time in seconds and the coefficient β is the natural log of the percent change in pupil diameter per second. Values range from -0.30 to -0.01. More positive values represent slower pupil redilation and are associated with greater, potentially beneficial ipRGC activity.

    Baseline

Secondary Outcomes (7)

  • Accommodative Amplitude

    Baseline

  • Lag of Accommodation

    Baseline

  • Accommodative Facility

    Baseline

  • Slowing of Myopia Progression - Axial Length

    Two year change (Baseline to 2-Year visit)

  • Rebound of Progression - Axial Length

    One year change (2-year visit to 3-year visit)

  • +2 more secondary outcomes

Study Arms (1)

Contact lens

The first two years of the study all participants will wear +2.50 D multifocal contact lenses. The last year of the study, all subjects will be wearing single vision contact lenses.

Device: Contact lenses

Interventions

2.50 D multifocal contact lens years 1 and 2. Year 3 all wear a single vision contact lens.

Contact lens

Eligibility Criteria

Age10 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Only those participants in the original BLINK Study who have consented to continue will be enrolled in BLINK2.

You may qualify if:

  • Participants in the BLINK Study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ohio State University

Columbus, Ohio, 43210, United States

Location

University of Houston

Houston, Texas, 77204, United States

Location

Related Publications (1)

  • Chandler MA, Robich ML, Jordan LA, Mutti DO, Berntsen DA, Fenton R, Day E, Walline JJ; BLINK2 Study Group. Accommodation in Children after 4.7 Years of Multifocal Contact Lens Wear in the BLINK Study Randomized Clinical Trial. Optom Vis Sci. 2023 Jul 1;100(7):425-431. doi: 10.1097/OPX.0000000000002040. Epub 2023 Jun 24.

MeSH Terms

Conditions

Myopia

Interventions

Contact Lenses

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Intervention Hierarchy (Ancestors)

LensesOptical DevicesEquipment and Supplies

Results Point of Contact

Title
Dr. Jeffrey Walline
Organization
The Ohio State University

Study Officials

  • Jeffrey J Walline, OD PhD

    The Ohio State University College of Optometry

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 27, 2019

First Posted

September 6, 2019

Study Start

September 9, 2019

Primary Completion

January 4, 2024

Study Completion

January 4, 2024

Last Updated

May 6, 2026

Results First Posted

May 6, 2026

Record last verified: 2026-03

Locations